In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Zebra Technologies’ current price exceeds the PERT fair value by 7%, indicating potential overvaluation with high downside risk per Monte Carlo analysis showing all scenarios below current price. Valuation discrepancies arise from conflicting metrics, notably an EV/EBITDA outlier inflating estimates. Financial health signals moderate profitability and leverage but weak liquidity and growth, suggesting increased volatility and investment risk.